Current Biology of MTP: Implications for Selective Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-04 ,pp. : 283-300

Bentham Science Publishers

Access to resources Recommend Favorite

Individualisation of treatment regimens and goals is recommended for managing familial dyslipidaemias

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 7, 2007-07 ,pp. : 12-19

Adis International

Access to resources Recommend Favorite

Putting the ‘HAT’ back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions

By Sleiman Sama F   Basso Manuela   Mahishi Lata   Kozikowski Alan P   Donohoe Mary E   Langley Brett   Ratan Rajiv R  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 573-584

Informa Healthcare

Access to resources Recommend Favorite

The bottle's nearly empty? Treatment of drug addiction

By Luty J.   Rajagopal Arokiadass S. M.  

Journal of Substance Use, Vol. 14, Iss. 3-4, 2009-06 ,pp. : 175-178

Radcliffe Press

Access to resources Recommend Favorite

Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology

By Chistiakov Dimitry A.   Sobenin Igor A.   Orekhov Alexander N.  

Drug Delivery, Vol. 19, Iss. 8, 2012-11 ,pp. : 392-405

Informa Healthcare

Access to resources Recommend Favorite